Radium-223

Mar 31, 2020

Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed Global Clinical Development Group

Sep 20, 2019

Bayer data at ESMO 2019 highlights innovation in cancer research

Apr 09, 2019

Dr Gillies O'Bryan-Tear Joins Clarity Pharmaceuticals' Board

Mar 27, 2019

Bayer Data at AACR 2019 Underscores Company's Commitment to Advancing the Future of Cancer Care

Mar 25, 2019

Dr Thomas Ramdahl Joins Clarity Pharmaceuticals' Board

Feb 05, 2019

Bayer to Showcase New Data from its Growing Cancer Portfolio at 2019 ASCO GU Cancers Symposium

May 31, 2018

Bayer Partners with U.S. Department of Energy to Produce Key Starting Material for Xofigo® (radium Ra 223 dichloride) Injection

Apr 05, 2018

Bayer to Showcase Data from Diverse Oncology Pipeline at AACR 2018

Mar 16, 2018

Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain

Feb 07, 2018

Bayer to Feature Prostate Cancer Research at ASCO GU 2018 Symposium

Dec 04, 2017

Updated larotrectinib pediatric Phase I clinical trial data demonstrates response in TRK fusion cancers

Oct 05, 2017

Q BioMed Announces Launch of PainFreeCancer.com Website in Support of Non-Opioid Cancer Pain Drug